⚙
AI-generated deep summary
by qwen3.7-flash, 2026-11-18
· read from full text
ⓘ
This paper presents a methodological framework and reproducible R code for an artificial intelligence pipeline designed to address epidemiological spectrum bias and phenotypic overlap between endometriosis, irritable bowel syndrome, and inflammatory bowel disease. The proposed five-layer validation approach includes generative simulation of patient data, predictive modeling using random forests calibrated for concurrent conditions, safety mechanisms for out-of-distribution rejection, and comprehensive evaluation metrics including fairness auditing. The authors provide fully annotated scripts to ensure regulatory alignment with FDA standards and TRIPOD+AI guidelines for software as a medical device. This paper is centrally about endometriosis — specifically focusing on improving the accuracy and fairness of AI diagnostic pipelines by accounting for comorbidities that mimic its symptoms.
Abstract
This repository contains the detailed Supplementary Methods (Methodological Framework and Simulation Architecture for the Comorbidity-Aware Endometriosis AI Pipeline) and the fully annotated, reproducible R script accompanying the manuscript: "Epidemiological spectrum bias in endometriosis AI: a simulation-based perspective and a comorbidity-aware validation framework". Methodological Summary: To address epidemiological spectrum bias and phenotypic overlap between endometriosis (ENDO), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), we provide a five-layer, regulatory-aligned (FDA SaMD & TRIPOD+AI) validation framework: Layer 1 (Generative):Conditional Gaussian copula simulation calibrated to literature-derived age and ethnicity marginals (Bougie et al., BJOG 2019) and multi-organ biomarker profiles (pelvic pain, GI dysfunction, hs-CRP). Layer 2 (Predictive):Random forest classifiers trained on referral-centre cohorts. Layer 3 (Calibration): Multivariate Vector Platt Scaling adjusting ENDO logits for concurrent IBS/IBD confounding. Layer 4 (Safety): Dual-tier deferral mechanism combining Mahalanobis distance out-of-distribution (OOD) rejection and ambiguity deferral. Layer 5 (Evaluation):30-iteration Monte Carlo external validation auditing discrimination (ROC/DeLong), calibration (ECE, Brier score), clinical utility (Decision Curve Analysis), and race-stratified fairness. Software Requirements: Before running the script, users must install the following required CRAN packages: tidyverse (data manipulation and piping, MASS (multivariate normal generation via mvrnorm for the Gaussian copula), ranger (fast random forest modelling), scales (graphical scaling and formatting), ggplot2(publication-grade data visualisation), and patchwork (multi-panel figure composition).
Full text
1,958 characters
· extracted from
oa-doi-fallback
· click to expand
Methodological Framework and Reproducible R Code for the Five-Layer Comorbidity-Aware Endometriosis AI Pipeline
Authors/Creators
Description
This repository contains the detailed Supplementary Methods (Methodological Framework and Simulation Architecture for the Comorbidity-Aware Endometriosis AI Pipeline) and the fully annotated, reproducible R script accompanying the manuscript: "Epidemiological spectrum bias in endometriosis AI: a simulation-based perspective and a comorbidity-aware validation framework".
Methodological Summary: To address epidemiological spectrum bias and phenotypic overlap between endometriosis (ENDO), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), we provide a five-layer, regulatory-aligned (FDA SaMD & TRIPOD+AI) validation framework:
Layer 1 (Generative):Conditional Gaussian copula simulation calibrated to literature-derived age and ethnicity marginals (Bougie et al., BJOG 2019) and multi-organ biomarker profiles (pelvic pain, GI dysfunction, hs-CRP). Layer 2 (Predictive):Random forest classifiers trained on referral-centre cohorts. Layer 3 (Calibration): Multivariate Vector Platt Scaling adjusting ENDO logits for concurrent IBS/IBD confounding. Layer 4 (Safety): Dual-tier deferral mechanism combining Mahalanobis distance out-of-distribution (OOD) rejection and ambiguity deferral. Layer 5 (Evaluation):30-iteration Monte Carlo external validation auditing discrimination (ROC/DeLong), calibration (ECE, Brier score), clinical utility (Decision Curve Analysis), and race-stratified fairness.
Software Requirements: Before running the script, users must install the following required CRAN packages: tidyverse (data manipulation and piping, MASS (multivariate normal generation via mvrnorm for the Gaussian copula), ranger (fast random forest modelling), scales (graphical scaling and formatting), ggplot2(publication-grade data visualisation), and patchwork (multi-panel figure composition).
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.